Literature DB >> 2126000

Antitumor effect of PSK at a distant site: inductions of interleukin-8-like factor and macrophage chemotactic factor in murine tumor.

T Ebina1, K Murata.   

Abstract

The antitumor effect of PSK, a Coriolus preparation, at a distant site was analyzed with the use of a double grafted tumor system in which male BALB/c mice received simultaneous intradermal inoculations of Meth-A tumor in the right (10(6) cells) and the left (2 x 10(5) cells) flanks and were then injected with PSK in the right tumor on the third day thereafter. The antitumor effect of intratumoral administration of PSK in the right tumor on days 3, 4 and 5 was compared with the effect of surgical resection of the right tumor on day 5. Three out of 8 mice given PSK intratumorally became tumor-free whereas no mouse tumor-free in the left flank was found among the surgically resected mice. As regards sinecomitant immunity, tumor inoculation into the right flank followed by intra-tumoral administration of PSK on days 3 and 5 and surgical excision of the primary tumor on day 6 resulted in complete rejection of a tumor challenge in the left flank on day 21. The combination of presurgical intratumoral injections of PSK (more than 2 times) and postoperative oral administration of PSK appeared to be most effective in eradicating secondary tumors. Isolated TILs (tumor-infiltrating lymphocytes), obtained from the right tumor (treated with PSK) and the left tumor on day 10 in the double grafted tumor system were cultured in RPMI1640 with 10% fetal calf serum for 24 h. The culture supernatants were harvested and tested for the presence of chemotactic activity for neutrophils or macrophages. Significant neutrophil chemotactic factor (NCF) and macrophage chemotactic factor (MCF) activities were detected in the culture media from PSK-treated TILs that had been cultured for 24 h. Neither significant neutrophil nor macrophage chemotactic activity was detected in the media from untreated TILs. NCF and MCF activities were also detected in the culture supernatant from PSK-treated tumor tissue on day 6. PSK-induced NCF in the murine tumor was neutralized by treatment with anti-human IL-8 IgG, and might be murine IL-8-like factor. Therefore, neutrophil and macrophage infiltrations of tumors following intratumoral injections of PSK are probably mediated by inductions of IL-8-like factor and MCF.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2126000      PMCID: PMC5918000          DOI: 10.1111/j.1349-7006.1990.tb02695.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


neutrophil chemotactic factor macrophage chemotactic factor interleukin‐1 interleukin‐8 monocyte chemotactic and activating factor tumor‐infiltrating lymphocytes fetal calf serum peritoneal exudate cells
  18 in total

1.  Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE.

Authors:  T Yoshimura; N Yuhki; S K Moore; E Appella; M I Lerman; E J Leonard
Journal:  FEBS Lett       Date:  1989-02-27       Impact factor: 4.124

2.  Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines.

Authors:  T Yoshimura; K Matsushima; S Tanaka; E A Robinson; E Appella; J J Oppenheim; E J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor.

Authors:  C G Larsen; A O Anderson; J J Oppenheim; K Matsushima
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

4.  The "double grafted tumor system", proposed to find effector cells in the analyses of antitumor effect of BRMs.

Authors:  H Kohya; T Ebina; T Yamaguchi; N Ishida
Journal:  Biotherapy       Date:  1989

5.  Chemotactic factor and P15E-related chemotaxis inhibitor in human melanoma cell lines with different macrophage content and tumorigenicity in nude mice.

Authors:  A Benomar; W J Ming; G Taraboletti; P Ghezzi; C Balotta; G J Cianciolo; R Snyderman; J F Doré; A Mantovani
Journal:  J Immunol       Date:  1987-04-01       Impact factor: 5.422

6.  Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8.

Authors:  N Mukaida; M Shiroo; K Matsushima
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

7.  Cloning and sequencing of the cDNA for human monocyte chemotactic and activating factor (MCAF).

Authors:  Y Furutani; H Nomura; M Notake; Y Oyamada; T Fukui; M Yamada; C G Larsen; J J Oppenheim; K Matsushima
Journal:  Biochem Biophys Res Commun       Date:  1989-02-28       Impact factor: 3.575

8.  Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line.

Authors:  K Matsushima; C G Larsen; G C DuBois; J J Oppenheim
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

9.  Antitumor effect of interleukin-1 beta in the double grafted tumor system.

Authors:  T Ebina; K Ishikawa
Journal:  Jpn J Cancer Res       Date:  1989-06

10.  Antitumor effector mechanism at a distant site in the double grafted tumor system of PSK, a protein-bound polysaccharide preparation.

Authors:  T Ebina; H Kohya
Journal:  Jpn J Cancer Res       Date:  1988-08
View more
  4 in total

1.  Circulating promyelocytes and low levels of CD16 expression on polymorphonuclear leukocytes accompany early-onset periodontitis.

Authors:  E Nemoto; M Nakamura; S Shoji; H Horiuchi
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

2.  Analysis of effector T cells against the murine syngeneic tumor MethA in mice orally administered antitumor polysaccharide SPR-901.

Authors:  Y Takeda; M Tanaka; H Miyazaki; S Takeo; K Nomoto; Y Yoshikai
Journal:  Cancer Immunol Immunother       Date:  1994-03       Impact factor: 6.968

3.  Antitumor effect of PSK at a distant site: tumor-specific immunity and combination with other chemotherapeutic agents.

Authors:  T Ebina; K Murata
Journal:  Jpn J Cancer Res       Date:  1992-07

4.  Antitumor effect of intratumoral administration of biological response modifiers: induction of immunosuppressive acidic protein, a type of alpha 1-acid glycoprotein, in mice.

Authors:  T Ebina; K Murata; K Tamura
Journal:  Jpn J Cancer Res       Date:  1994-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.